Researchers created a novel molecular diagnostic platform that can detect COVID-19 genes after only 8 cycles of amplification, significantly reducing the time required for diagnosis. The new SERS-PCR platform uses gold nanoparticles to produce high-sensitivity signals, providing an important tool in the fight against the pandemic.
Rice University researchers developed a microfluidic platform to analyze how infectious bacteria evolve resistance to antibiotics. The platform allows for controlled environments and fine-tuning of conditions, revealing previously unknown pathways to resistance.
Researchers developed a mathematical model that can predict resistance outcomes for various drug pairs. The model, called JDFE, characterizes mutations available to bacteria and allows for classification of drug pairs into those that facilitate or hinder multi-drug resistance.
Researchers at Nagoya City University developed a novel approach for surface disinfection using harmless visible light, inactivating bacteria and viruses. The study's findings suggest that photothermal effects caused by pulsed laser irradiation can instantly destroy pathogenic microorganisms.
Researchers have pinpointed a gene in E. coli ST131 that makes it highly resistant to antibiotics, leading to new treatment strategies and improved tracking of emerging resistance. The study aims to create better treatments to stop deadly E. coli infections.
A CHOP study found that infants born via uncomplicated cesarean delivery have a low risk of early-onset sepsis and should not receive antibiotics at birth. The study's findings could help clinicians tailor antibiotic use in newborns, reducing complications and unnecessary treatment.
A new EU-funded project, MUSIC, will investigate how bacterial defences influence the spread of mobile genetic elements (MGEs) between bacteria. MGEs can change key traits of bacteria, including antibiotic resistance and virulence.
Hospital admissions for common and severe childhood infections in England decreased by up to 94% during the first year of the COVID-19 pandemic. This suggests that non-COVID-19 interventions, such as school closures and social distancing measures, may also reduce transmission of other infectious diseases in children.
Researchers found that inhibiting gasdermin D, a protein involved in septic patients' organ lesions, can prevent multiple-organ damage and improve prognosis. Disulfiram, a drug originally indicated for alcohol dependence, was shown to inhibit gasdermin D and reduce tissue injury.
Researchers discovered a bacterial toxin that can accelerate colon cancer in mice, sharing similarities with human tumors. The study's findings suggest a potential link between transient food poisoning and colorectal cancer development, highlighting the need for further epidemiological studies.
Researchers found that adding tomato concentrate to a mouse's diet reduced intestinal and systemic inflammation in individuals with chronic HIV. The study suggests targeting the inflamed intestine may be a novel way to prevent persistent inflammation.
A new study by the University of Exeter reveals two previously unknown Vibrio species in UK waters, which can cause gastroenteritis and skin infections in humans. The increasing range of these bacteria also threatens marine biodiversity and the seafood industry, with potential economic costs estimated at £6 billion annually.
The study proposes a novel nonequilibrium mechanism for allosteric regulation of motor switching, based on precise measurement of the bacterial flagellar motor's switching dynamics at stall. This mechanism has implications for other molecular motors and explains dynamic properties under all loads uniformly.
Researchers at the University of Louisville School of Dentistry found that oral bacteria like Porphyromonas gingivalis can suppress the production and effectiveness of proteins that protect humans from viral infection. This suppression increases vulnerability to infection, allowing viruses to enter the body more easily.
Researchers at Rockefeller University have discovered a novel compound called macolacin that is highly potent against multidrug-resistant bacteria, including those resistant to colistin. The compound was discovered using an evolutionary approach to antibiotic discovery and has shown promising results in lab experiments.
A study published in Nature found that a type of MRSA called mecC-MRSA originated in hedgehogs over 200 years ago, long before the clinical use of antibiotics. The researchers believe that the bacteria evolved as an adaptation to living on the skin of hedgehogs with a fungus that produces its own antibiotics.
Phages weigh all options and make an informed decision whether to exit the dormant state and attack their bacterial host. The study found that some phage families have developed a complex decision-making strategy, receiving information from neighboring bacteria and controlling communication via arbitrium.
Researchers developed a promising alternative to traditional wet-chemistry methods using plasma-enabled surface engineering. The technology can create contact-killing, antifouling, and drug-release surfaces, accelerating antimicrobial material development.
A new species of antibiotic-resistant bacteria, Enterococcus innesii, has been discovered by researchers at the John Innes Centre. The strain is resistant to vancomycin and may cause hospital-acquired infections.
A team of researchers has fully identified the production process of thymol and carvacrol in thyme and oregano, respectively. The findings could lead to improved plant breeding and the development of new antibacterial and anti-inflammatory substances.
Researchers used PET scans to quantify antibiotic levels in orthopaedic implants, discovering rifampin penetration is only about 14% as much as previously believed. A higher dose of rifampin achieved higher bacterial killing and fewer antibiotic-resistant strains, suggesting a shorter treatment regimen may be effective.
Researchers identified 'pre-resistance' signs in bacteria, predicting future resistance to antibiotics. This discovery allows doctors to select the best treatments for bacterial infections and paves the way for personalized genomic therapy.
A new blood test developed at Hebrew University of Jerusalem detects immune and inflammatory activity in tissues by monitoring circulating DNA fragments. This method provides accurate information about immune processes in remote tissues, removing the need for invasive measures.
Scientists have measured the speed of Candidatus Liberibacter asiaticus, a bacterium causing citrus greening disease. The bacteria can colonize a tree in around 80-100 days, faster than symptoms appear, making it difficult to control.
Scientists have discovered a new potential treatment to reverse antibiotic resistance in bacteria causing sepsis, pneumonia, and urinary tract infections. The indole carboxylates class of enzyme blockers can stop MBL resistance enzymes from working, allowing antibiotics like carbapenems to effectively target bacteria.
Researchers discovered that blood stem cells use high-energy fatty acids from the body's fat stores to power up their response to infection. This finding could lead to new approaches in treating bacterial infections, particularly in vulnerable and older individuals.
Researchers developed an AI program that accurately identified patients at risk of serious illness due to blood infections, with an accuracy rate of 82%. The technology has the potential to serve as an early warning system for doctors, enabling them to rank patients based on their risk level.
The study found clear differences in bacterial community composition and functional profiles between healthy and diseased sites, with specific taxa associated with periodontal disease progression. The identification of key bacterial species and functions involved could help prevent permanent damage.
Researchers at USC developed a new peptide that stimulates the host's immune response to fight bacterial infections, offering an alternative to antibiotics. The peptide, MTD12813, is highly effective in clearing infections and modulates inflammation, reducing the risk of complications.
A new study by researchers at the University of Copenhagen found that an imbalance in vaginal bacteria is associated with a higher risk of emergency caesarean section. The study analyzed 1,396 samples from 736 pregnant women and discovered that those with greater levels of imbalance were more likely to deliver via C-section.
The University of Cincinnati College of Medicine has developed an ointment called AB569 that kills virtually all pathogenic bacteria, including multidrug resistant Pseudomonas aeruginosa. This study shows the topical drug enhances wound healing in various burn injuries.
Researchers have developed a comprehensive Lyme disease dashboard to define hotspots and map the disease across the US and Canada. The dashboard provides valuable insights for public health awareness and research collaboration.
Researchers from Trinity College Dublin investigate the epidemiology and population biology of Enteroccocus faecium, a high-priority pathogen. They found that Irish isolates have evolved independently and are diverse, with a unique genetic transposon element encoding vancomycin resistance.
A recent study found that antibiotic resistance rates for Helicobacter pylori are decreasing in European countries. The use of three antibiotics over 10-14 days resulted in success rates of over 90%. The researchers hope to reduce antibiotic consumption to prevent further resistance.
Researchers at Karolinska Institutet found that certain bacteria from the digestive system can cause damage to pancreatic cells, increasing the risk of malignant tumours. The study suggests that antibiotics could prevent this damage, offering a potential prophylactic intervention.
Scientists have clarified phytochrome's atomic-scale resolution, unlocking its role in regulating bacterial pathogenicities. The study provides a new photoactivation model explaining the signaling mechanism of black rot disease.
Researchers have found that ultrashort-pulse lasers can inactivate antibiotic-resistant bacteria and bacterial spores, reducing their numbers by over 1,000 times. The technology has the potential to be used to sterilize wounds and disinfect blood products, and may also be used to treat bloodstream infections.
Researchers at Harvard's Wyss Institute have developed a microfluidic Organ Chip device that accurately models cystic fibrosis lung airway pathology. The model replicates key pathological hallmarks, including mucus layer changes and inflammatory responses, providing a comprehensive preclinical human model for investigating new therapies.
Researchers at the University of Texas at Dallas have developed a vaccine method against recurrent urinary tract infections (UTIs) using metal-organic frameworks. The new approach produces substantially enhanced antibody production and significantly higher survival rates in mice compared to standard vaccine preparation methods.
Researchers from SMART and TLL have developed a rapid Raman spectroscopy-based method to detect and quantify early bacterial infection in crops. This method enables non-invasive early diagnosis, which is crucial for plant disease management and agricultural productivity.
Research using ring-tailed lemurs shows that fecal microbiota transplants can stabilize and restore a healthy gut microbiome after antibiotic use. The study confirms the effectiveness of this ancient treatment for reducing the negative effects of antibiotics on the gut, which can cause severe diarrhea and abdominal pain.
A study by Anglia Ruskin University has identified potentially dangerous Pseudomonas bacteria in 21% of wild bird faeces collected from locations near the River Cam. The bacteria, which can be passed on to humans through cross-contamination, were resistant to multiple antibiotics.
Researchers have identified compounds that interfere with fungal enzymes required for fatty acid synthesis, potentially overcoming resistance to current treatments. These compounds show promise as antifungal agents, effective even against drug-resistant strains of fungi.
Researchers at Hebrew University of Jerusalem discover a 'disrupted' state in bacteria that resists current antibiotics, requiring new pharmacological agents to combat. The breakthrough model predicts bacterial population responses to treatments, offering avenues for better treatments against cancer cells.
A rapid same-day test has been developed to identify secondary infections in COVID-19 patients on intensive care, allowing for targeted antibiotic treatment and reduced risk of antimicrobial resistance. The test uses nanopore sequencing technology to analyze bacterial and fungal pathogens present in patient samples.
Scientists at the University of Southampton have created nanoparticles that can target and kill deadly bacteria hiding in human cells. The breakthrough could lead to a new treatment method using injectable or inhalation-based antibiotic-laden capsules, potentially saving thousands of lives annually.
Zheng's sensor can determine effective antibiotics for treating bacterial infections in patients, providing detailed information about microbial growth faster and more sensitively than conventional approaches. The device achieves single-cell spatial resolution and 15-second temporal resolution over a centimeter-scale field of view.
Research identifies way of using nanoparticles to target and disrupt bacterial cells, making them more susceptible to standard antibiotic treatments. Laboratory studies show a strong effect in killing a range of bacteria, including some linked to hospital-acquired infections.
A new technique measures bacterial metabolic activity with an electric probe to identify antibiotic resistance in less than 90 minutes. This rapid method enables doctors to quickly determine which antibiotics will or won't work for a patient's infection, improving treatment decisions and potentially saving lives.
A global review found bioaerosols can be transmitted throughout a building by defective plumbing and that opening toilet lids after flushing disperses contaminated droplets. Uncovered rubbish bins and poor surface cleaning also contribute to high bacterial loads.
The study found that all 86 tridomain homologues of NDP-heptose synthetases are conserved in Actinobacteria, with three types of gene clusters encoding different natural products. The kinase domains of four selected proteins were found to be dysfunctional.
Researchers at Karolinska Institutet discovered that interleukin-26 plays a critical role in bacterial pneumonia by directly killing bacteria and modulating the immune system. This finding positions IL-26 as a new potential target for biological treatment of pneumonia, an increasing global health threat.
A new study reveals that mice infected with bacteria or parasites develop a unique tolerance mechanism to shield their enteric neurons from death. This finding has potential clinical implications for conditions like irritable bowel syndrome, where neuronal loss can lead to severe gastrointestinal disease.
A study published in The Lancet Infectious Diseases found that temocillin was effective in treating febrile urinary tract infections with fewer resistant bacteria. Temocillin acts specifically against E. coli and other intestinal bacteria, reducing the risk of treatment failure.
Chromobacterium violaceum uses zinc ion transporter ZnuABC to overcome host constraints on metal availability, increasing its virulence. The discovery offers a route for novel therapies against bacterial infections.
A new research discovery at Monash University has found a way to make antibiotics more effective against 'superbugs' by attaching chemoattractants to antibiotics, enabling the recruitment of immune cells and improving killing ability. The findings have shown a 2-fold increase in effectiveness with lower doses.
Researchers have recorded the sharpest images of living bacteria, revealing a complex architecture that makes them harder to kill by antibiotics. The study found that bacteria with protective outer layers may have stronger and weaker spots on their surface.
Researchers found a higher burden of infection, more inflammation, and lower diversity of microorganisms in children with cystic fibrosis compared to disease controls. This divergence was noted as early as toddlerhood, suggesting potential for earlier treatment and prevention of severe lung disease.
Researchers at the University of Bonn discovered a novel resistance mechanism in Staphylococcus aureus, which protects the bacteria from vancomycin. By binding vancomycin to its cell wall, the strain prevents the antibiotic from reaching the membrane and killing the bacteria.
Researchers found that Pseudomonas aeruginosa populations in CF patients' sinuses vary widely, with evolution following two stages: pathoadaptive community formation and fragmentation. This discovery may inform new therapeutic approaches by focusing on strongest evolutionary pressures.